• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

Is there anything worse than Cardinal Health?

To add to things, cardinal just laid off all inventory personnel (up to and including directors). Hundreds of jobs gone. You won’t see them talking about it though, only about how they’re “creating one functional inventory planning and purchasing team”. I’m sure it has absolutely nothing to do with the hundreds of millions they’re paying out to settle this lawsuit they got themselves into.
This is a sad but predictable consequence of Cardinal's historical inventory practices + upcoming D.S.C.S.A. enforcement + artificial intelligence